BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18225540)

  • 1. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
    Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
    Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
    Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
    Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
    Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 was involved in the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients.
    Zhu XS; Shi W; An GY; Zhang HM; Song YG; Li YB
    Chin Med J (Engl); 2011 Aug; 124(16):2423-30. PubMed ID: 21933581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
    Fujisaki T; Otsuka T; Gondo H; Okamura T; Niho Y; Ohhinata A; Abe F
    Int Immunopharmacol; 2003 Jun; 3(6):901-7. PubMed ID: 12781706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of interphase fluorescence in situ hybridization for determination of the tumor load in chronic myeloid leukemia].
    Du QF; Zhou SY; Liu XL; Song LL; Zhang Y
    Ai Zheng; 2003 Jun; 22(6):612-5. PubMed ID: 12948411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
    Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
    Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocytes in chronic myelogenous leukaemia (CML): no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients.
    Garicochea B; Chase A; Lazaridou A; Goldman JM
    Leukemia; 1994 Jul; 8(7):1197-201. PubMed ID: 8035612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of human bone marrow mesenchymal stem cells on proliferation of chronic myeloid leukemia cells.
    Zhang HM; Zhang LS
    Ai Zheng; 2009 Jan; 28(1):29-32. PubMed ID: 19448412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
    Orsini E; Calabrese E; Maggio R; Pasquale A; Nanni M; Trasarti S; Tafuri A; Guarini A; Foa R
    Leuk Res; 2006 Jul; 30(7):785-94. PubMed ID: 16527350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
    Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.
    Miura I; Takahashi N; Kobayashi Y; Saito K; Miura AB
    Int J Hematol; 2000 Oct; 72(3):310-7. PubMed ID: 11185986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.